330 related articles for article (PubMed ID: 17084127)
1. Weight gain in children with hypertonia of cerebral origin receiving intrathecal baclofen therapy.
McCoy AA; Fox MA; Schaubel DE; Ayyangar RN
Arch Phys Med Rehabil; 2006 Nov; 87(11):1503-8. PubMed ID: 17084127
[TBL] [Abstract][Full Text] [Related]
2. Continuously infused intrathecal baclofen over 12 months for spastic hypertonia in adolescents and adults with cerebral palsy.
Meythaler JM; Guin-Renfroe S; Law C; Grabb P; Hadley MN
Arch Phys Med Rehabil; 2001 Feb; 82(2):155-61. PubMed ID: 11239304
[TBL] [Abstract][Full Text] [Related]
3. Survival of individuals with cerebral palsy receiving continuous intrathecal baclofen treatment: a matched-cohort study.
Krach LE; Kriel RL; Day SM; Strauss DJ
Dev Med Child Neurol; 2010 Jul; 52(7):672-6. PubMed ID: 19811519
[TBL] [Abstract][Full Text] [Related]
4. Weight changes in children receiving intrathecal baclofen for the treatment of spasticity.
Pritula SL; Fox MA; Ayyangar R
J Pediatr Rehabil Med; 2012; 5(3):197-201. PubMed ID: 23023252
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal baclofen management of poststroke spastic hypertonia: implications for function and quality of life.
Ivanhoe CB; Francisco GE; McGuire JR; Subramanian T; Grissom SP
Arch Phys Med Rehabil; 2006 Nov; 87(11):1509-15. PubMed ID: 17084128
[TBL] [Abstract][Full Text] [Related]
6. Epilepsy and intrathecal baclofen therapy in children with cerebral palsy.
Buonaguro V; Scelsa B; Curci D; Monforte S; Iuorno T; Motta F
Pediatr Neurol; 2005 Aug; 33(2):110-3. PubMed ID: 16087055
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a randomised controlled trial.
Hoving MA; van Raak EP; Spincemaille GH; Palmans LJ; Becher JG; Vles JS;
Eur J Paediatr Neurol; 2009 May; 13(3):240-6. PubMed ID: 18595749
[TBL] [Abstract][Full Text] [Related]
8. Performance and complications associated with the synchromed 10-ml infusion pump for intrathecal baclofen administration in children.
Albright AL; Awaad Y; Muhonen M; Boydston WR; Gilmartin R; Krach LE; Turner M; Zidek KA; Wright E; Swift D; Bloom K
J Neurosurg; 2004 Aug; 101(1 Suppl):64-8. PubMed ID: 16206974
[TBL] [Abstract][Full Text] [Related]
9. The risk of progression of scoliosis in cerebral palsy patients after intrathecal baclofen therapy.
Senaran H; Shah SA; Presedo A; Dabney KW; Glutting JW; Miller F
Spine (Phila Pa 1976); 2007 Oct; 32(21):2348-54. PubMed ID: 17906577
[TBL] [Abstract][Full Text] [Related]
10. A clinical study of intrathecal baclofen using a programmable pump for intractable spasticity.
Guillaume D; Van Havenbergh A; Vloeberghs M; Vidal J; Roeste G
Arch Phys Med Rehabil; 2005 Nov; 86(11):2165-71. PubMed ID: 16271565
[TBL] [Abstract][Full Text] [Related]
11. Effect of intrathecal baclofen on dystonia in children with cerebral palsy and the use of functional scales.
Motta F; Stignani C; Antonello CE
J Pediatr Orthop; 2008 Mar; 28(2):213-7. PubMed ID: 18388717
[TBL] [Abstract][Full Text] [Related]
12. Improvements in children with cerebral palsy following intrathecal baclofen: use of the Rehabilitation Institute of Chicago Care and Comfort Caregiver Questionnaire (RIC CareQ).
Baker KW; Tann B; Mutlu A; Gaebler-Spira D
J Child Neurol; 2014 Mar; 29(3):312-7. PubMed ID: 23420651
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of posterior spinal fusion and instrumentation in patients with continuous intrathecal baclofen infusion pumps.
Caird MS; Palanca AA; Garton H; Hensinger RN; Ayyangar RN; Drongowski A; Farley FA
Spine (Phila Pa 1976); 2008 Feb; 33(4):E94-9. PubMed ID: 18277862
[TBL] [Abstract][Full Text] [Related]
14. The role of intrathecal baclofen in the management of primary and secondary dystonia in children.
Woon K; Tsegaye M; Vloeberghs MH
Br J Neurosurg; 2007 Aug; 21(4):355-8. PubMed ID: 17676454
[TBL] [Abstract][Full Text] [Related]
15. Satisfaction of individuals treated long-term with continuous infusion of intrathecal baclofen by implanted programmable pump.
Krach LE; Nettleton A; Klempka B
Pediatr Rehabil; 2006; 9(3):210-8. PubMed ID: 17050399
[TBL] [Abstract][Full Text] [Related]
16. Infections related to intrathecal baclofen therapy in children and adults: frequency and risk factors.
Fjelstad AB; Hommelstad J; Sorteberg A
J Neurosurg Pediatr; 2009 Nov; 4(5):487-93. PubMed ID: 19877786
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal baclofen therapy: benefits and complications.
Zdolsek HA; Olesch C; Antolovich G; Reddihough D
J Intellect Dev Disabil; 2011 Sep; 36(3):207-13. PubMed ID: 21830852
[TBL] [Abstract][Full Text] [Related]
18. Complications of intrathecal baclofen pump therapy in pediatric patients.
Borowski A; Littleton AG; Borkhuu B; Presedo A; Shah S; Dabney KW; Lyons S; McMannus M; Miller F
J Pediatr Orthop; 2010; 30(1):76-81. PubMed ID: 20032747
[TBL] [Abstract][Full Text] [Related]
19. [Results of intrathecal baclofen therapy on spasticity in patients with brain injury].
Dénes Z; Klauber A; Both B; Lóránd E
Ideggyogy Sz; 2012 Jul; 65(7-8):243-8; discussion 248. PubMed ID: 23074844
[TBL] [Abstract][Full Text] [Related]
20. [Quality of life in cerebral palsy children treated with intrathecal baclofen pump implantation in parents' opinion].
Borowski A; Pruszczyński B; Miller F; Synder M
Chir Narzadow Ruchu Ortop Pol; 2010; 75(5):318-22. PubMed ID: 21853903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
